Virus spike protein Recombinant antibody, PBS Only
spike protein Recombinant Antibody for Indirect ELISA, WB
Host / Isotype
Rabbit / IgG
Reactivity
virus
Applications
Indirect ELISA, WB
Conjugate
Unconjugated
CloneNo.
4I18
Cat no : 82734-4-PBS
Synonyms
Validation Data Gallery
Tested Applications
Recommended dilution
| Application | Dilution |
|---|---|
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Product Information
82734-4-PBS targets spike protein in Indirect ELISA, WB applications and shows reactivity with virus samples.
| Tested Reactivity | virus |
| Host / Isotype | Rabbit / IgG |
| Class | Recombinant |
| Type | Antibody |
| Immunogen | spike protein fusion protein Ag30684 相同性解析による交差性が予測される生物種 |
| Full Name | SARS-CoV-2 Spike Protein |
| Calculated molecular weight | 141 kDa |
| GenBank accession number | NC_045512 |
| Gene symbol | SARS-COV-2 |
| Gene ID (NCBI) | 43740568 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| Storage Buffer | PBS Only |
| Storage Conditions | Store at -80°C. |
Background Information
Coronaviruses (CoVs) infect human and animals and cause varieties of diseases, including respiratory, enteric, renal, and neurological diseases. CoV uses its spike protein to recognize ACE2 as its receptors and mediate membrane fusion and virus entry into host cells(PMID: 32221306). Each monomer of trimeric S protein is about 180 kDa, and contains two subunits, S1 and S2,S1 recognizes and binds to host receptors, and subsequent conformational changes in S2 facilitate fusion between the viral envelope and the host cell membrane(PMID: 19198616). Although the amino acid sequences of the S-glycoprotein were found to be different between the various HCoV, the structures showed high similarity, but the best 3D structural overlap shared by SARS-CoV and SARS-CoV-2, consistent with the shared ACE2 predicted receptor (PMID: 32522207). The spike protein of CoVs can be a target for vaccine and therapeutic development (PMID: 19198616). 28901-1-AP is specific for spike protein of SARS-COV-2, that antigen region is 428-506aa.
